Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Conditions
Lupus Nephritis (LN)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic, Rochester, Minnesota, United States
Baylor College of Medicine, Houston, Texas, United States
Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, New Aquitaine, France
University Hospital Regensburg, Regensburg, Bavaria, Germany
University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, South Korea
Seoul National University Hospital, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea
Hospital Universitario Virgen del Rocio, Seville, Andalusia, Spain
Clinica Universidad de Navarra, Pamplona, Navarre, Spain
Hospital Gregorio Maranon, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Regional Universitario de Malaga, Málaga, Spain
Changhua Christian Hospital, Changhua, Taiwan
Taichung General Veterans Hospital, Taichung, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals